Christopher H. Hill

1.7k total citations
22 papers, 1.5k citations indexed

About

Christopher H. Hill is a scholar working on Molecular Biology, Organic Chemistry and Biomaterials. According to data from OpenAlex, Christopher H. Hill has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Biomaterials. Recurrent topics in Christopher H. Hill's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Phytochemistry and Bioactive Compounds (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Christopher H. Hill is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Phytochemistry and Bioactive Compounds (5 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Christopher H. Hill collaborates with scholars based in United Kingdom, United States and Switzerland. Christopher H. Hill's co-authors include John Nixon, Sandra E. Wilkinson, Peter D. Davis, Elizabeth Keech, Geoffrey Lawton, J. Wadsworth, D. Westmacott, Lucy H. Elliott, William R. Harris and D. Bradshaw and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Christopher H. Hill

22 papers receiving 1.4k citations

Peers

Countries citing papers authored by Christopher H. Hill

Since Specialization

Citations

This map shows the geographic impact of Christopher H. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Hill more than expected).

Fields of papers citing papers by Christopher H. Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher H. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Hill. The network helps show where Christopher H. Hill may publish in the future.

Co-authorship network of co-authors of Christopher H. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher H. Hill. A scholar is included among the top collaborators of Christopher H. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher H. Hill. Christopher H. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells 1999 ·Cancer Chemotherapy and Pharmacology ·Janet E. Merritt, John A. Sullivan, Lisa Drew, Abida Khan, Kevin L. Wilson, (unknown), William R. Harris, D. Bradshaw, Christopher H. Hill, Martin G. Rumsby, (unknown)	19
2	Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors 1997 ·Biochemical Journal ·K M K Bottomley, Neera Borkakoti, D. Bradshaw, Paul A. Brown, Michael J. Broadhurst, (unknown), Lucy H. Elliott, (unknown), Trevor J. Hallam, B.K. Handa, Christopher H. Hill, (unknown), (unknown), Geoffrey Lawton, Janet E. Merritt, John Nixon, (unknown), (unknown), William H. Johnson	32
3	Bisindolylmaleimide inhibitors of protein kinase C. Further conformational restriction of a tertiary amine side chain. 1994 ·Bioorganic & Medicinal Chemistry Letters ·Peter D. Davis, Trevor J. Hallam, William R. Harris, Christopher H. Hill, Geoffrey Lawton, John Nixon, Janet L. Smith, D. Vesey, Sandra E. Wilkinson	9
4	Therapeutic potential of protein kinase C inhibitors 1993 ·Inflammation Research ·D. Bradshaw, Christopher H. Hill, John Nixon, Sandra E. Wilkinson	134
5	Protein kinase C inhibitors 1993 ·Drugs of the Future ·William J. Harris, Christopher H. Hill, E. J. Lewis, John Nixon, Sandra E. Wilkinson	18
6	Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction 1993 ·Journal of Medicinal Chemistry ·Rino A. Bit, Peter D. Davis, Lucy H. Elliott, William R. Harris, Christopher H. Hill, Elizabeth Keech, (unknown), Geoffrey Lawton, (unknown), John Nixon, D. Vesey, J. Wadsworth, Sandra E. Wilkinson	145
7	Oxidative cyclisations with palladium acetate. A short synthesis of staurosporine aglycone. 1993 ·Tetrahedron Letters ·William R. Harris, Christopher H. Hill, Elizabeth Keech, (unknown)	64
8	A convenient synthesis of bisindolylmaleimides 1993 ·Tetrahedron Letters ·Rino A. Bit, Peter H. Crackett, William R. Harris, Christopher H. Hill	9
9	Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor 1992 ·Inflammation Research ·(unknown), D. Bradshaw, Peter D. Davis, Lucy H. Elliott, Thomas Griffiths, Christopher H. Hill, (unknown), Geoffrey Lawton, John Nixon, A. D. Sedgwick, J. Wadsworth, D. Westmacott, Sandra E. Wilkinson	9
10	Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides 1992 ·Journal of Medicinal Chemistry ·Peter D. Davis, Christopher H. Hill, Geoffrey Lawton, John Nixon, Sandra E. Wilkinson, Steve Hurst, Elizabeth Keech, (unknown)	144
11	Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity 1992 ·Journal of Medicinal Chemistry ·Peter D. Davis, Lucy H. Elliott, William R. Harris, Christopher H. Hill, Steve Hurst, Elizabeth Keech, (unknown), Geoffrey Lawton, John Nixon, Sandra E. Wilkinson	199
12	The design and biological properties of potent and selective inhibitors of protein kinase C 1992 ·Biochemical Society Transactions ·John Nixon, Joshua D. Bishop, D. Bradshaw, Peter D. Davis, Christopher H. Hill, Lucy H. Elliott, (unknown), Geoffrey Lawton, E. J. Lewis, (unknown), D. Westmacott, J. Wadsworth, Sandra E. Wilkinson	64
13	A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuli 1991 ·FEBS Letters ·(unknown), M.Maureen Dale, Peter D. Davis, Lucy H. Elliott, Christopher H. Hill, (unknown), Geoffrey Lawton, Breda M. Twomey, J. Wadsworth, Sandra E. Wilkinson, John Nixon	52
14	A Dieckmann/ring expansion approach to tetrahydropyrido- and tetrahydroazepino-[1,2-a]indoles 1991 ·Tetrahedron ·Rino A. Bit, Peter D. Davis, Christopher H. Hill, Elizabeth Keech, D. Vesey	26
15	Oral anti-inflammatory activity of a potent, selective, protein kinase C inhibitor 1991 ·International Journal of Immunopharmacology ·D. Bradshaw, (unknown), E. J. Lewis, Joshua D. Bishop, (unknown), J Nixon, Sandra E. Wilkinson, Lucy H. Elliott, D. Westmacott, J. Wadsworth, (unknown), Thomas Griffiths, A. D. Sedgwick, Peter D. Davis, Christopher H. Hill, Geoffrey Lawton	1
16	The design of inhibitors of protein kinase C; the solution conformation of staurosporine 1991 ·Journal of the Chemical Society Chemical Communications ·Peter D. Davis, Christopher H. Hill, W. A. Thomas, Ian Whitcombe	12
17	Synthesis and antiviral activity of metabolites of rimantadine 1990 ·Journal of Medicinal Chemistry ·Percy S. Manchand, (unknown), Joseph A. Martin, Christopher H. Hill, John H. Merrett, Elizabeth Keech, Robert B. Belshe, (unknown), Iain S. Sim	33
18	K252a is a potent and selective inhibitor of phosphorylase kinase 1990 ·Biochemical and Biophysical Research Communications ·Lucy H. Elliott, Sandra E. Wilkinson, (unknown), Christopher H. Hill, Geoffrey Lawton, Peter D. Davis, John Nixon	59
19	Potent selective inhibitors of protein kinase C 1989 ·FEBS Letters ·Peter D. Davis, Christopher H. Hill, Elizabeth Keech, Geoffrey Lawton, John Nixon, (unknown), J. Wadsworth, D. Westmacott, Sandra E. Wilkinson	439
20	Functionalisation of saturated hydrocarbons. Part 7. On the mechanism of the degradation of the cholesterol side-chain to 20-ketone by oxidation with the Gif system 1986 ·Journal of the Chemical Society Perkin Transactions 1 ·D. H. R. BARTON, Jean Boivin, David Crich, Christopher H. Hill	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact